Cancer Research UK logo.
SearchDonate
  • Search

A trial looking at azacitidine for acute myeloid leukaemia or myelodysplasia (AMADEUS)

Overview

Cancer types:

Acute leukaemia, Acute myeloid leukaemia (AML), Blood cancers, Leukaemia, Myelodysplastic syndrome (MDS)

Status:

Closed

Phase:

Phase 3

Details

This trial is looking at having a drug called azacitidine after a stem cell transplant.

It is for people who are having a with somebody else’s cells. This is called an .

Recruitment start: 4 June 2019

Recruitment end: 27 March 2023

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Professor Charles Craddock

Supported by

Birmingham University

IMPACT Partnership

Last reviewed: 05 Apr 2023

CRUK internal database number: 16166

Help and support